Literature DB >> 1738192

Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.

Y Shirazi1, P M Pitha.   

Abstract

In this study, we have analyzed the effect of human alpha interferon (IFN-alpha) on a single replication cycle of human immunodeficiency virus type 1 (HIV-1) infection in the lymphocytic cell line CEM-174, which is highly sensitive to the antiviral effects of IFN. Pretreatment of cells with 50 to 500 U of recombinant human IFN-alpha per ml resulted in a marked reduction in viral RNA and protein synthesis. The effect of IFN-alpha was dose dependent and was amplified in multiple infection cycles. IFN-induced inhibition of viral protein synthesis could be detected only when cells were treated with IFN-alpha prior to infection or when IFN-alpha was added up to 10 h postinfection, but not if IFN-alpha was added at the later stages of HIV-1 replication cycle or after the HIV-1 infection was already established. Analysis of the integrated HIV-1 provirus showed a marked decrease in the levels of proviral DNA in IFN-treated cells. Thus, in contrast to the previous studies on established HIV-1 infection in T cells, in which the IFN block appeared to be at the posttranslational level, during de novo infection, IFN-alpha interferes with an early step of HIV-1 replication cycle that occurs prior to the integration of the proviral DNA. These results indicate that the early IFN block of HIV-1 replication, which has been previously observed only in primary marcophages, can also be detected in the IFN-sensitive T cells, indicating that the early IFN block is not limited to macrophages.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738192      PMCID: PMC240853     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  HIV replication can be blocked by recombinant human interferon beta.

Authors:  B Michaelis; J A Levy
Journal:  AIDS       Date:  1989-01       Impact factor: 4.177

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The effects of interferon in mouse cells infected with MuLV.

Authors:  P M Pitha
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

4.  Effect of interferon on the exogenous Friend murine leukemia virus infection.

Authors:  C H Riggin; P M Pitha
Journal:  Virology       Date:  1982-04-15       Impact factor: 3.616

5.  Effect of interferon on exogenous, endogenous, and chroniv murine leukemia virus infection.

Authors:  P M Pitha; W P Rowe; M N Oxman
Journal:  Virology       Date:  1976-04       Impact factor: 3.616

6.  Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.

Authors:  M S Smith; R J Thresher; J S Pagano
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

7.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

8.  Effect of interferon on the replication of mink cell focus-inducing virus in murine cells: synthesis, processing, assembly, and release of viral proteins.

Authors:  J A Bilello; N A Wivel; P M Pitha
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

9.  Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.

Authors:  H E Gendelman; L M Baca; J Turpin; D C Kalter; B Hansen; J M Orenstein; C W Dieffenbach; R M Friedman; M S Meltzer
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  71 in total

1.  Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.

Authors:  David M Asmuth; Robert L Murphy; Susan L Rosenkranz; Juan J L Lertora; Shyam Kottilil; Yoninah Cramer; Ellen S Chan; Robert T Schooley; Charles R Rinaldo; Nathan Thielman; Xiao-Dong Li; Sharon M Wahl; Jessica Shore; Jennifer Janik; Richard A Lempicki; Yaa Simpson; Richard B Pollard
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

2.  Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15.

Authors:  Atsushi Okumura; Gengshi Lu; Ian Pitha-Rowe; Paula M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-24       Impact factor: 11.205

3.  Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.

Authors:  Ryuta Sakuma; Amber A Mael; Yasuhiro Ikeda
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

4.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

5.  A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation.

Authors:  Theresa Li-Yun Chang; Arevik Mosoian; Richard Pine; Mary E Klotman; John P Moore
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15.

Authors:  Zhizhou Kuang; Eun Joo Seo; Jonathan Leis
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

7.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  Protective effect of interferon beta on human T cell leukaemia virus type I infection of CD4+ T cells isolated from human cord blood.

Authors:  B Macchi; I Faraoni; A Mastino; C D'Onofrio; G Romeo; E Bonmassar
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

9.  The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.

Authors:  W Popik; P M Pitha
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Effects of type I interferons on Friend retrovirus infection.

Authors:  Nicole Gerlach; Simone Schimmer; Siegfried Weiss; Ulrich Kalinke; Ulf Dittmer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.